<ul data-eligibleForWebStory="false"><li>The Delhi High Court directed the drug controller general of India to decide on a plea regarding weight loss medicines within three months.</li><li>The plea raised concerns over the approval process of drug combinations used in weight management treatments.</li><li>The petitioner alleged that licences for weight loss drugs were issued without proper scientific trials or consideration of potential health risks.</li><li>The court instructed the DCGI to consult experts, stakeholders, and drug manufacturers and make a decision within three months.</li></ul>

Delhi HC Directs DCGI To Decide On Plea Flagging Concerns Over Approvals Of Weight Loss Drugs

Discover more